86 related articles for article (PubMed ID: 12899756)
1. [Using GST-tag to capture protein interaction of an interferon-inducible systemic lupus associated gene, IFIT1].
Ye S; Pang H; Gu YY; Shen N; Chen SL; Chen XG; Hua J; Qian J; Rao ZH
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):770-3. PubMed ID: 12899756
[TBL] [Abstract][Full Text] [Related]
2. Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1.
Ye S; Pang H; Gu YY; Hua J; Chen XG; Bao CD; Wang Y; Zhang W; Qian J; Tsao BP; Hahn BH; Chen SL; Rao ZH; Shen N
Rheumatology (Oxford); 2003 Oct; 42(10):1155-63. PubMed ID: 12777642
[TBL] [Abstract][Full Text] [Related]
3. [Interferon-inducible genes lymphocyte antigen 6 complex E and tetratricopeptide repeats 1 are correlated with clinical features of patients with systemic lupus erythematosus].
Tang JP; Gu YY; Shen N; Ye S; Qian J; Hua J; Chen XG; Chen SL; Bao CD; Wang Y; Zhang W
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1157-60. PubMed ID: 15387975
[TBL] [Abstract][Full Text] [Related]
4. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus.
Nzeusseu Toukap A; Galant C; Theate I; Maudoux AL; Lories RJ; Houssiau FA; Lauwerys BR
Arthritis Rheum; 2007 May; 56(5):1579-88. PubMed ID: 17469140
[TBL] [Abstract][Full Text] [Related]
5. A proteomic study of peripheral blood mononuclear cells in systemic lupus erythematosus.
Dai Y; Hu C; Huang Y; Huang H; Liu J; Lv T
Lupus; 2008 Sep; 17(9):799-804. PubMed ID: 18755861
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus.
Landolt-Marticorena C; Bonventi G; Lubovich A; Ferguson C; Unnithan T; Su J; Gladman DD; Urowitz M; Fortin PR; Wither J
Ann Rheum Dis; 2009 Sep; 68(9):1440-6. PubMed ID: 18772188
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Li D; Song L; Fan Y; Li X; Li Y; Chen J; Zhu F; Guo C; Shi Y; Zhang L
Clin Immunol; 2009 Dec; 133(3):422-7. PubMed ID: 19748832
[TBL] [Abstract][Full Text] [Related]
8. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.
Kirou KA; Lee C; George S; Louca K; Papagiannis IG; Peterson MG; Ly N; Woodward RN; Fry KE; Lau AY; Prentice JG; Wohlgemuth JG; Crow MK
Arthritis Rheum; 2004 Dec; 50(12):3958-67. PubMed ID: 15593221
[TBL] [Abstract][Full Text] [Related]
9. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
11. Measurement of activity of rho GTPases during mitosis.
Oceguera-Yanez F; Narumiya S
Methods Enzymol; 2006; 406():332-45. PubMed ID: 16472668
[TBL] [Abstract][Full Text] [Related]
12. [Gene expression profiling of peripheral leukocytes from patients with systemic lupus erythematosus using oligonucleotide DNA microarray].
Wu YS; Fan RQ; Chen DC; Xuan GW
Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):929-34. PubMed ID: 16109543
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
Ripley BJ; Rahman MA; Isenberg DA; Latchman DS
Arthritis Rheum; 2005 Apr; 52(4):1171-9. PubMed ID: 15818685
[TBL] [Abstract][Full Text] [Related]
14. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP
Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
[TBL] [Abstract][Full Text] [Related]
15. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
[TBL] [Abstract][Full Text] [Related]
16. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.
Bertsias GK; Nakou M; Choulaki C; Raptopoulou A; Papadimitraki E; Goulielmos G; Kritikos H; Sidiropoulos P; Tzardi M; Kardassis D; Mamalaki C; Boumpas DT
Arthritis Rheum; 2009 Jan; 60(1):207-18. PubMed ID: 19116915
[TBL] [Abstract][Full Text] [Related]
17. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
Arora V; Verma J; Dutta R; Marwah V; Kumar A; Das N
Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
[TBL] [Abstract][Full Text] [Related]
18. Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients.
Ishii T; Onda H; Tanigawa A; Ohshima S; Fujiwara H; Mima T; Katada Y; Deguchi H; Suemura M; Miyake T; Miyatake K; Kawase I; Zhao H; Tomiyama Y; Saeki Y; Nojima H
DNA Res; 2005; 12(6):429-39. PubMed ID: 16769699
[TBL] [Abstract][Full Text] [Related]
19. Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes.
Nagai T; Arinuma Y; Yanagida T; Yamamoto K; Hirohata S
Arthritis Rheum; 2005 Mar; 52(3):847-55. PubMed ID: 15751081
[TBL] [Abstract][Full Text] [Related]
20. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
